All News

FDA has approved cholic acid (Cholbam), a once-daily treatment for pediatric and adult patients who have bile acid synthesis disorders due to single enzyme defects. It is also approved as an adjunct to standard care for patients with peroxisomal disorders, such as Zellweger spectrum disorders.

Most primary care physicians are aware of prescription drug monitoring programs (PMPs) designed to prevent doctor shopping, but more than four out of 10 are not using them, according to a survey published in the March issue of Health Affairs.

NACDS has acquired a program that trains pharmacists to administer point-of-care testing in pharmacies; it will kick off in April with a tour of pharmacy schools nationwide.